Viewing Study NCT03359460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-02-11 @ 10:08 PM
Study NCT ID: NCT03359460
Status: COMPLETED
Last Update Posted: 2021-10-19
First Post: 2017-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
Sponsor: Brian Jonas
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Previously Treated Myelodysplastic Syndrome View
None Refractory High Risk Myelodysplastic Syndrome View
None Secondary Myelodysplastic Syndrome View
None Therapy-Related Myelodysplastic Syndrome View
Keywords: